Our Team
Merav is a seasoned regulatory affairs professional with over 30 years of experience in the pharmaceutical industry. As Senior Vice President of Pharmacovigilance, Medical Information, and Regulatory Affairs Operations for Lifecycle Services at Clinigen, she leads a global team dedicated to ensuring patient safety and regulatory affairs strategy and submissions.
Trained as a pharmacist with a master’s degree in Biopharmacy from King’s College London, Merav brings a deep understanding of drug development and lifecycle management. Having joined Clinigen in 2014, her expertise is instrumental in guiding Clinigen’s global projects through complex regulatory landscapes.
Merav is passionate about building high-performing teams and fostering a culture of excellence. Under her leadership, the Clinigen team delivers exceptional pharmacovigilance, medical information, and regulatory support to clients worldwide.
Sarah joined Clinigen in 2016 and provides pharmacovigilance oversight across the Clinigen Group, both for the products for which Clinigen is the Marketing Authorisation Holder, as well as for PV Services provided to Clients for early access programmes. Prior to this she spent 17 years in multi-aspect Pharmacovigilance roles, starting her career at the MHRA, then working in a number of global positions for both small-medium and large Pharmaceutical companies.
With a background in medicinal chemistry(PhD), Melanie has over 15 years’ experience in regulatory affairs within pharma and consultancy. Melanie specializes in regulatory strategy and execution in product acquisition, authorisation and licence optimisation.
Elizabeth has extensive understanding of the complex environment of unlicensed medicines and early access, having worked in this field for over 10 years. Elizabeth advises pharmaceutical and biotech companies on regulatory strategies and compliance throughout Managed Access Programmes to enable best outcomes in product development and patient access.
Michelle joined Clinigen in 2018 and works with internal and external stakeholders on the development of regulatory strategy for compliant access programs. Additionally, she has regulatory responsibility for a licensed product within Clinigen. Prior to joining Clinigen, she held a variety of roles across Pharmacovigilance, Auditing, Health Economics and Regulatory Affairs. Michelle has a BSc degree from Stellenbosch University, South Africa.
Natalie McGregor joined Clinigen in 2019 and is currently Senior Regulatory Affairs Manager for Clinigen's products, and works with internal and external stakeholders on the development of regulatory strategy for compliant Managed Access Programs. Prior to joining Clinigen she held a variety of Regulatory Affairs roles in the pharmaceutical and biotech industries including in clinical and medical device trials. Natalie has a PhD in Biochemistry.